Tag: biotechnology

The 2023 Prime Minister's Prizes for Science are highlighting and celebrating Australian accomplishments in quantum science, biotechnology, and outstanding teaching, with the awardees being honoured and celebrated for their significant contributions.

Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).

Breakthrough Victoria has announced that it is investing in medical technology company Atmo Biosciences and its world-first gas-sensing capsule designed to help diagnose functional gastrointestinal disorders. 

Dr Jiawen Li, a biomedical engineer from the University of Adelaide who developed a 3D-printed ultrathin endoscope, was named in the MIT Technology Review 2023 global list of Innovators Under 35. 

Global semiconductor developer BluGlass Limited is slated to unveil its improved gallium nitride (GaN) products at the Laser World of Photonics, Europe’s industry conference, taking place in Munich, Germany this week. 

Biotechnology company Vaxxas has completed work on its new needle-free vaccine technology manufacturing facility in Northshore Hamilton. 

CSIRO has announced a four-year, $25 million investment in a new program that will combine engineering and biology to drive innovations within the biotechnology industry.

Symbio Laboratories is opening a new research and development centre in Melbourne that will advance Victoria’s capabilities in biotechnology and molecular biology, cementing the state’s status as Australia’s life sciences hub. 

Two projects involving medical and scientific researchers from the University of Sydney have secured government funding through the Cooperative Research Centres Projects’ (CRC-P) latest round. 

Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, recently announced they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.